LivaNova PLC LIVN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression, alo…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited Kingdom
Employees3,300
TickerLIVN
Statistics
Market Cap$4.30B
Revenue (TTM)$1.39B
Net Income-$242.5M
Net Margin-17.5%
EPS$1.96
P/E40.79
P/S3.06
P/B3.62
EV/EBITDA15.98
ROE9.5%
Dividend Yield—
Price$78.36
Data: Twelve Data · Revenue = mcap / P/S